A new study details how a nasal spray formulated by investigators from Brigham and Women's Hospital may work to protect ...

Preclinical proof-of-concept package to be presented at Industry Summit on RAS being held September 24-26, 2024NEW YORK and ...

Voyager Therapeutics (VYGR – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

Scientists have found that the naked mole-rat—an underground rodent that lives up to 40 years—has lost a number of CD1 ...

Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) today presented data from preclinical experiments showing the high potential ...

Anyone with any experience as an investor knows that while penny stocks can produce strong returns, they’re also risky. You ...

Scientists have uncovered critical differences between how innate-like T cells mature in humans and mice. Early in life, most innate-like T cells in the human thymus aren't able to use all of their ...

Italian biotech Aptadir Therapeutics has launched with the promise that its pipeline of preclinical RNA inhibitors could ...

Read here for an analysis of Zai Lab’s (ZLAB) strategic global partnerships, leading products, and growth potential in the ...

Tolerability issues for CT-388 and CT-996 may impact Roche Holdings AG, but strong pipeline prospects remain. Discover why ...

New proteomic analyses show that rezpegaldesleukin increases the protein levels of immune-regulating pathways while reducing specific serum proteins known to be elevated in patients with atopic ...

VANCOUVER, Washington, Sept. 24, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential ...